Lifestyle changes for the treatment of nonalcoholic fatty liver disease: A review of observational studies and intervention trials

Therapeutic Advances in Gastroenterology

Volumn 9, Issue 3, 2016, Pages 392-407

  Zelber Sagi, Shira ^a,b   Godos, Justyna ^c   Salomone, Federico ^d  

^a UNIVERSITY OF HAIFA   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c UNIVERSITY OF CATANIA   (Italy)

^d Azienda Sanitaria Provinciale di Catania   (Italy)

Author keywords

coffee; diet; lifestyle; nonalcoholic fatty liver disease; physical activity

Indexed keywords

ALANINE AMINOTRANSFERASE; CARBOHYDRATE; CHOLESTEROL; DOCOSAHEXAENOIC ACID; FAT; FRUCTOSE; ICOSAPENTAENOIC ACID; MONOUNSATURATED FATTY ACID; OLIVE OIL; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; SUCROSE; TRIACYLGLYCEROL;

AEROBIC EXERCISE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALLELE; BODY MASS; CALORIC RESTRICTION; CARBOHYDRATE INTAKE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); COFFEE; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DRUG EFFICACY; FAT INTAKE; FOOD COMPOSITION; GENOTYPE; HUMAN; INTERVENTION STUDY; LIFESTYLE MODIFICATION; LIPID LIVER LEVEL; MEDITERRANEAN DIET; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); NONALCOHOLIC FATTY LIVER; NONHUMAN; OBSERVATIONAL STUDY; PHASE 2 CLINICAL TRIAL (TOPIC); PHYSICAL ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; RESISTANCE TRAINING; REVIEW; SOFT DRINK; THERAPY EFFECT; WEIGHT REDUCTION;

EID: 84963735801     PISSN: 1756283X     EISSN: 17562848     Source Type: Journal    
DOI: 10.1177/1756283X16638830     Document Type: Review

References (137)

1. Abdelmalek M., Suzuki A., Guy C., Unalp-Arida A., Colvin R., Johnson R., et al. (2010) Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology 51: 1961-1971.
2. Abid A., Taha O., Nseir W., Farah R., Grosovski M., Assy N., (2009) Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome. J Hepatol 51: 918-924.
3. Afzali A., Weiss N., Boyko E., Ioannou G., (2010) Association between serum uric acid level and chronic liver disease in the United States. Hepatology 52: 578-589.
4. Andersen T., Gluud C., Franzmann M., Christoffersen P., (1991) Hepatic effects of dietary weight loss in morbidly obese subjects. J Hepatol 12: 224-229.
5. Anty R., Marjoux S., Iannelli A., Patouraux S., Schneck A., Bonnafous S., et al. (2012) Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery. J Hepatol 57: 1090-1096.
6. Argo C., Patrie J., Lackner C., Henry T., De Lange E., Weltman A., et al. (2015) Effects of n-3 fish oil on metabolic and histological parameters in nash: a double-blind, randomized, placebo-controlled trial. J Hepatol 62: 190-197.
7. Assy N., Nasser G., Kamayse I., Nseir W., Beniashvili Z., Djibre A., et al. (2008) soft drink consumption linked with fatty liver in the absence of traditional risk factors. Can J Gastroenterol 2: 811-816.
8. Bacchi E., Negri C., Targher G., Faccioli N., Lanza M., Zoppini G., et al. (2013) both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 randomized trial). Hepatology 58: 1287-1295.
9. Bambha K., Wilson L., Unalp A., Loomba R., Neuschwander-Tetri B., Brunt E., et al. (2014) Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis. Liver Int 34: 1250-1258.
10. Banerji M., Faridi N., Atluri R., Chaiken R., Lebovitz H., (1999) Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. J Clin Endocrinol Metab 84: 137-144.
11. Bedogni G., Bellentani S., (2004) Fatty liver: how frequent is it and why? Ann Hepatol 3: 63-65.
12. Bellentani S., Saccoccio G., Masutti F., Croce L., Brandi G., Sasso F., et al. (2000) Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 132: 112-117.
13. Bergheim I., Weber S., Vos M., Kramer S., Volynets V., Kaserouni S., et al. (2008) Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. J Hepatol 48: 983-992.
14. Bozzetto L., Prinster A., Annuzzi G., Costagliola L., Mangione A., Vitelli A., et al. (2012) Liver fat is reduced by an isoenergetic MUFA diet in a controlled randomized study in type 2 diabetic patients. Diabetes Care 35: 1429-1435.
15. Browning J., Baker J., Rogers T., Davis J., Satapati S., Burgess S., (2011) short-term weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction. Am J Clin Nutr 93: 1048-1052.
16. Chalasani N., Younossi Z., Lavine J., Diehl A., Brunt E., Cusi K., et al. (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55: 2005-2023.
17. Chang Y., Ryu S., Sung E., Woo H., Cho S., Yoo S., et al. (2009) Weight gain within the normal weight range predicts ultrasonographically detected fatty liver in healthy Korean men. Gut 58: 1419-1425.
18. Chen G., Liang G., Ou J., Goldstein J., Brown M., (2004) Central role for Liver X receptor in insulin-mediated activation of SREBP-1C transcription and stimulation of fatty acid synthesis in liver. Proc Natl Acad Sci U S A 101: 11245-11250.
19. Chitturi S., Abeygunasekera S., Farrell G., Holmes-Walker J., Hui J., Fung C., et al. (2002) NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 35: 373-379.
20. Choi J., Ford E., Gao X., Choi H., (2008) Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: the third National Health and Nutrition Examination Survey. Arthritis Rheum 59: 109-116.
21. Church T., Kuk J., Ross R., Priest E., Biltoft E., Blair S., (2006) Association of cardiorespiratory fitness, body mass index, and waist circumference to nonalcoholic fatty liver disease. Gastroenterology 130: 2023-2030.
22. Cortez-Pinto H., Jesus L., Barros H., Lopes C., Moura M., Camilo M., (2006) how different is the dietary pattern in non-alcoholic steatohepatitis patients? Clin Nutr 25: 816-823.
23. Davis J., Le K., Walker R., Vikman S., Spruijt-Metz D., Weigensberg M., et al. (2010) Increased hepatic fat in overweight Hispanic youth influenced by interaction between genetic variation in PNPLA3 and high dietary carbohydrate and sugar consumption. Am J Clin Nutr 92: 1522-1527.
24. Del Gaudio A., Boschi L., Del Gaudio G., Mastrangelo L., Munari D., (2002) Liver damage in obese patients. Obesity Surgery 12: 802-804.
25. Dixon J., Bhathal P., Hughes N., O'Brien P., (2004) Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss. Hepatology 39: 1647-1654.
26. Eckel R., Jakicic J., Ard J., De Jesus J., Houston Miller N., Hubbard V., et al. (2014) 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 129: S76-S99.
27. Erdmann J., Kallabis B., Oppel U., Sypchenko O., Wagenpfeil S., Schusdziarra V., (2008) Development of hyperinsulinemia and insulin resistance during the early stage of weight gain. Am J Physiol Endocrinol Metab 294: E568-E575.
28. Eriksson S., Eriksson K., Bondesson L., (1986) Nonalcoholic steatohepatitis in obesity: a reversible condition. Acta Medica Scandinavica 220: 83-88.
29. Falck-Ytter Y., Younossi Z., Marchesini G., Mccullough A., (2001) clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis 21: 17-26.
30. Federico A., Dallio M., Godos J., Loguercio C., Salomone F., (2016) Targeting gut-liver axis for the treatment of nonalcoholic steatohepatitis: translational and clinical evidence. Transl Res 167: 116-124.
31. Finucane F., Sharp S., Purslow L., Horton K., Horton J., Savage D., et al. (2010) The effects of aerobic exercise on metabolic risk, insulin sensitivity and intrahepatic lipid in healthy older people from the Hertfordshire cohort study: a randomised controlled trial. Diabetologia 53: 624-631.
32. Fon Tacer K., Rozman D,. (2011) Nonalcoholic fatty liver disease: focus on lipoprotein and lipid deregulation. J Lipids 2011: 783976.
33. Gaby A., (2005) Adverse effects of dietary fructose. Altern Med Rev 10: 294-306.
34. Garg A., (1998) High-monounsaturated-fat diets for patients with diabetes mellitus: a meta-analysis. Am J Clin Nutr 67: 577S-582S.
35. Godos J., Pluchinotta F., Marventano S., Buscemi S., Li Volti G., Galvano F., et al. (2014) Coffee components and cardiovascular risk: beneficial and detrimental effects. Int J Food Sci Nutr 65: 925-936.
36. Goran M., Walker R., Allayee H., (2012) Genetic-related and carbohydrate-related factors affecting liver fat accumulation. Curr Opin Clin Nutr Metab Care 15: 392-396.
37. Grosso G., Mistretta A., Frigiola A., Gruttadauria S., Biondi A., Basile F., et al. (2014) Mediterranean diet and cardiovascular risk factors: a systematic review. Crit Rev Food Sci Nutr 54: 593-610.
38. Grosso G., Stepaniak U., Micek A., Topor-Madry R., Pikhart H., Szafraniec K., et al. (2015) Association of daily coffee and tea consumption and metabolic syndrome: results from the Polish arm of the HAPIEE study. Eur J Nutr 54: 1129-1137.
39. Gupte P., Amarapurkar D., Agal S., Baijal R., Kulshrestha P., Pramanik S., et al. (2004) Non-alcoholic steatohepatitis in type 2 diabetes mellitus. J Gastroenterol Hepatol 19: 854-858.
40. Hallsworth K., Fattakhova G., Hollingsworth K., Thoma C., Moore S., Taylor R., et al. (2011) Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss. Gut 60: 1278-1283.
41. Harrison S., Fecht W., Brunt E., Neuschwander-Tetri B., (2009) Orlistat for overweight subjects with nonalcoholic steatohepatitis: a randomized, prospective trial. Hepatology 49: 80-86.
42. Haufe S., Engeli S., Kast P., Bohnke J., Utz W., Haas V., et al. (2011) randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects. Hepatology 53: 1504-1514.
43. Herman R., Zakim D., Stifel F., (1970) Effect of diet on lipid metabolism in experimental animals and man. Fed Proc 29: 1302-1307.
44. Hernandez R., Martinez-Lara E., Canuelo A., Del Moral M., Blanco S., Siles E., et al. (2005) Steatosis recovery after treatment with a balanced sunflower or olive oil-based diet: involvement of perisinusoidal stellate cells. World J Gastroenterol 11: 7480-7485.
45. Howard B., Wylie-Rosett J., (2002) Sugar and cardiovascular disease: a statement for healthcare professionals from the Committee on Nutrition of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association. Circulation 106: 523-527.
46. Huang M., Greenson J., Chao C., Anderson L., Peterman D., Jacobson J., et al. (2005) one-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study. Am J Gastroenterol 100: 1072-1081.
47. Hussein O., Grosovski M., Lasri E., Svalb S., Ravid U., Assy N., (2007) monounsaturated fat decreases hepatic lipid content in non-alcoholic fatty liver disease in rats. World J Gastroenterol 13: 361-368.
48. Ibanez J., Izquierdo M., Arguelles I., Forga L., Larrion J., Garcia-Unciti M., et al. (2005) Twice-weekly progressive resistance training decreases abdominal fat and improves insulin sensitivity in older men with type 2 diabetes. Diabetes Care 28: 662-667.
49. Ioannou G., Morrow O., Connole M., Lee S., (2009) Association between dietary nutrient composition and the incidence of cirrhosis or liver cancer in the United States population. Hepatology 50: 175-184.
50. Johnson N., Sachinwalla T., Walton D., Smith K., Armstrong A., Thompson M., et al. (2009) Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. Hepatology 50: 1105-1112.
51. Katan M., (2009) Weight-loss diets for the prevention and treatment of obesity. N Engl J Med 360: 923-925.
52. Keating S., Hackett D., George J., Johnson N., (2012) Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol 57: 157-166.
53. Keating S., Hackett D., Parker H., O'Connor H., Gerofi J., Sainsbury A., et al. (2015) Effect of aerobic exercise training dose on liver fat and visceral adiposity. J Hepatol 63: 174-182.
54. Kechagias S., Ernersson A., Dahlqvist O., Lundberg P., Lindstrom T., Nystrom F., (2008) Fast-food-based hyper-alimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects. Gut 57: 649-654.
55. Kim H., Park J., Lee K., Lee G., Jeon S., Kim J., et al. (2009) Effect of body weight and lifestyle changes on long-term course of nonalcoholic fatty liver disease in Koreans. Am J Med Sci 337: 98-102.
56. Kirk E., Reeds D., Finck B., Mayurranjan S., Patterson B., Klein S., (2009) Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction. Gastroenterology 136: 1552-1560.
57. Kistler K., Brunt E., Clark J., Diehl A., Sallis J., Schwimmer J., (2011) Physical Activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease. Am J Gastroenterol 106: 460-468; quiz 469.
58. Krasnoff J., Painter P., Wallace J., Bass N., Merriman R., (2008) Health-related fitness and physical activity in patients with nonalcoholic fatty liver disease. Hepatology 47: 1158-1166.
59. Lazo M., Solga S., Horska A., Bonekamp S., Diehl A., Brancati F., et al. (2010) Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes. Diabetes Care 33: 2156-2163.
60. Le K., Ith M., Kreis R., Faeh D., Bortolotti M., Tran C., et al. (2009) fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. Am J Clin Nutr 89: 1760-1765.
61. Lee J., Rhee P., Lee J., Lee K., Kim J., Koh K., et al. (1998) Role of hyperinsulinemia and glucose intolerance in the pathogenesis of nonalcoholic fatty liver in patients with normal body weight. Korean J Intern Med 13: 12-14.
62. Levy J., Clore J., Stevens W., (2004) Dietary n-3 polyunsaturated fatty acids decrease hepatic triglycerides in Fischer 344 Rats. Hepatology 39: 608-616.
63. Luyckx F., Desaive C., Thiry A., Dewe W., Scheen A., Gielen J., et al. (1998) Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty. International Journal of Obesity and Related Metabolic Disorders 22: 222-226.
64. Ma J., Fox C., Jacques P., Speliotes E., Hoffmann U., Smith C., et al. (2015) sugar-sweetened beverage, diet soda, and fatty liver disease in the Framingham Heart Study cohorts. J Hepatol 63: 462-469.
65. Maersk M., Belza A., Stodkilde-Jorgensen H., Ringgaard S., Chabanova E., Thomsen H., et al. (2012) Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study. Am J Clin Nutr 95: 283-289.
66. Magkos F., (2010) Exercise and fat accumulation in the human liver. Curr Opin Lipidol 21: 507-517.
67. Marchesini G., Ridolfi V., Nepoti V., (2008) Hepatotoxicity of fast food? Gut 57: 568-570.
68. Matsuzawa N., Takamura T., Kurita S., Misu H., Ota T., Ando H., et al. (2007) Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet. Hepatology 46: 1392-1403.
69. Mensink R., Zock P., Kester A., Katan M., (2003) Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 77: 1146-1155.
70. Molloy J., Calcagno C., Williams C., Jones F., Torres D., Harrison S., (2012) Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis. Hepatology 55: 429-436.
71. Musso G., Cassader M., Rosina F., Gambino R., (2012) Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials. Diabetologia 55: 885-904.
72. Musso G., Gambino R., De Michieli F., Cassader M., Rizzetto M., Durazzo M., et al. (2003) Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology 37: 909-916.
73. Nobili V., Bedogni G., Donati B., Alisi A., Valenti L., (2013) The I148M variant of PNPLA3 reduces the response to docosahexaenoic acid in children with non-alcoholic fatty liver disease. J Med Food 16: 957-960.
74. Oh S., Shida T., Yamagishi K., Tanaka K., So R., Tsujimoto T., et al. (2015) Moderate to vigorous physical activity volume is an important factor for managing non-alcoholic fatty liver disease: a retrospective Study. Hepatology 61: 1205-1215.
75. Orr J., Gentile C., Davy B., Davy K., (2008) Large artery stiffening with weight gain in humans: role of visceral fat accumulation. Hypertension 51: 1519-1524.
76. Ouyang X., Cirillo P., Sautin Y., Mccall S., Bruchette J., Diehl A., et al. (2008) Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol 48: 993-999.
77. Oza N., Eguchi Y., Mizuta T., Ishibashi E., Kitajima Y., Horie H., et al. (2009) A pilot trial of body weight reduction for nonalcoholic fatty liver disease with a home-based lifestyle modification intervention delivered in collaboration with interdisciplinary medical staff. J Gastroenterol 44: 1203-1208.
78. Pagano G., Pacini G., Musso G., Gambino R., Mecca F., Depetris N., et al. (2002) Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 35: 367-372.
79. Palmer M., Schaffner F., (1990) Effect of weight reduction on hepatic abnormalities in overweight patients. Gastroenterology 99: 1408-1413.
80. Parker H., Johnson N., Burdon C., Cohn J., O'Connor H., George J., (2012) Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol 56: 944-951.
81. Perk J., De Backer G., Gohlke H., Graham I., Reiner Z., Verschuren M., et al. (2012) European Practice guidelines on cardiovascular disease prevention in clinical (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 33: 1635-1701.
82. Perseghin G., Lattuada G., De Cobelli F., Ragogna F., Ntali G., Esposito A., et al. (2007) Habitual physical activity is associated with intrahepatic fat content in humans. Diabetes Care 30: 683-688.
83. Poulsom R., (1986) Morphological changes of organs after sucrose or fructose feeding. Prog Biochem Pharmacol 21: 104-134.
84. Promrat K., Kleiner D., Niemeier H., Jackvony E., Kearns M., Wands J., et al. (2010) Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 51: 121-129.
85. Propst A., Propst T., Judmaier G., Vogel W., (1995) Prognosis in nonalcoholic steatohepatitis. Gastroenterology 108: 1607.
86. Ratziu V., Bellentani S., Cortez-Pinto H., Day C., Marchesini G., (2010) A position statement on NAFLD/NASH based on the EASL 2009 Special Conference. J Hepatol 53: 372-384.
87. Repa J., Mangelsdorf D., (2002) The liver X receptor gene team: potential new players in atherosclerosis. Nat Med 8: 1243-1248.
88. Romeo S., Kozlitina J., Xing C., Pertsemlidis A., Cox D., Pennacchio L., et al. (2008) Genetic variation in PNPLa3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 40: 1461-1465.
89. Ruderman N., Chisholm D., Pi-Sunyer X., Schneider S., (1998) The metabolically obese, normal-weight individual revisited. Diabetes 47: 699-713.
90. Ryan M., Abbasi F., Lamendola C., Carter S., McLaughlin T., (2007) serum alanine aminotransferase levels decrease further with carbohydrate than fat restriction in insulin-resistant adults. Diabetes Care 30: 1075-1080.
91. Ryan M., Itsiopoulos C., Thodis T., Ward G., Trost N., Hofferberth S., et al. (2013) The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with nonalcoholic fatty liver disease. J Hepatol 59: 138-143.
92. Ryu S., Chang Y., Jung H., Yun K., Kwon M., Choi Y., et al. (2015) Relationship of sitting time and physical activity with non-alcoholic fatty liver disease. J Hepatol 63: 1229-1237.
93. Saab S., Mallam D., Cox Ii G., Tong M., (2013) Impact of coffee on liver diseases: a systematic review. Liver Int 34: 495-504.
94. Salamone F., Galvano F., Marino Gammazza A., Paternostro C., Tibullo D., Bucchieri F., et al. (2012a) Silibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitis. Dig Liver Dis 44: 334-342.
95. Salamone F., Li Volti G., Titta L., Puzzo L., Barbagallo I., La Delia F., et al. (2012b) Moro orange juice prevents fatty liver in mice. World J Gastroenterol 18: 3862-3868.
96. Salomone F., Li Volti G., Rosso C., Grosso G., Bugianesi E., (2013) Unconjugated bilirubin, a potent endogenous antioxidant, is decreased in patients with non-alcoholic steatohepatitis and advanced fibrosis. J Gastroenterol Hepatol 28: 1202-1208.
97. Salomone F., Li Volti G., Vitaglione P., Morisco F., Fogliano V., Zappala A., et al. (2014) Coffee enhances the expression of chaperones and antioxidant proteins in rats with nonalcoholic fatty liver disease. Transl Res 163: 593-602.
98. Santoro N., Savoye M., Kim G., Marotto K., Shaw M., Pierpont B., et al. (2012) hepatic fat accumulation is modulated by the interaction between the rs738409 variant in the PNPLA3 gene and the dietary omega6/omega3 PUFA intake. PLoS One 7: e37827.
99. Sanyal A., Abdelmalek M., Suzuki A., Cummings O., Chojkier M., (2014) No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial. Gastroenterology 147: 377-384.
100. Savard C., Tartaglione E., Kuver R., Haigh W., Farrell G., Subramanian S., et al. (2013) Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis. Hepatology 57: 81-92.
101. Sawada N., Inoue M., Iwasaki M., Sasazuki S., Shimazu T., Yamaji T., et al. (2012) Consumption of n-3 fatty acids and fish reduces risk of hepatocellular carcinoma. Gastroenterology 142: 1468-1475.
102. Schultz J., Tu H., Luk A., Repa J., Medina J., Li L., et al. (2000) Role of LXRS in control of lipogenesis. Genes Dev 14: 2831-2838.
103. Scorletti E., Bhatia L., Mccormick K., Clough G., Nash K., Hodson L., et al. (2014) Effects of purified eicosapentaenoic and docosahexaenoic acids in non-alcoholic fatty liver disease: results from the Welcome∗ study. Hepatology 60: 1211-1221.
104. Sekiya M., Yahagi N., Matsuzaka T., Najima Y., Nakakuki M., Nagai R., et al. (2003) Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression. Hepatology 38: 1529-1539.
105. Setiawan V., Wilkens L., Lu S., Hernandez B., Le Marchand L., Henderson B., (2015) Association of coffee intake with reduced incidence of liver cancer and death from chronic liver disease in the US multiethnic cohort. Gastroenterology 148: 118-125; quiz e115.
106. Sevastianova K., Kotronen A., Gastaldelli A., Perttila J., Hakkarainen A., Lundbom J., et al. (2011) Genetic variation in PNPLA3 (adiponutrin) confers sensitivity to weight loss-induced decrease in liver fat in humans. Am J Clin Nutr 94: 104-111.
107. Shah K., Stufflebam A., Hilton T., Sinacore D., Klein S., Villareal D., (2009) Diet and exercise interventions reduce intrahepatic fat content and improve insulin sensitivity in obese older adults. Obesity 17: 2162-2168.
108. Shim S., Jun D., Kim E., Saeed W., Lee K., Lee H., et al. (2013) Caffeine attenuates liver fibrosis via defective adhesion of hepatic stellate cells in cirrhotic model. J Gastroenterol Hepatol 28: 1877-1884.
109. Sigal R., Alberga A., Goldfield G., Prud'homme D., Hadjiyannakis S., Gougeon R., et al. (2014) Effects of aerobic training, resistance training, or both on percentage body fat and cardiometabolic risk markers in obese adolescents: the healthy eating aerobic and resistance training in youth randomized clinical trial. JAMA Pediatr 168: 1006-1014.
110. Slentz C., Bateman L., Willis L., Shields A., Tanner C., Piner L., et al. (2011) Effects of aerobic vs. resistance training on visceral and liver fat stores, liver enzymes, and insulin resistance by HOMA in overweight adults from STRRIDE AT/RT. Am J Physiol Endocrinol Metab 301: E1033-E1039.
111. Sobrecases H., Le K., Bortolotti M., Schneiter P., Ith M., Kreis R., et al. (2010) Effects of short-term overfeeding with fructose, fat and fructose plus fat on plasma and hepatic lipids in healthy men. Diabetes Metab 36: 244-246.
112. St George A., Bauman A., Johnston A., Farrell G., Chey T., George J., (2009) Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors. J Gastroenterol Hepatol 24: 399-407.
113. Storlien L., Kraegen E., Chisholm D., Ford G., Bruce D., Pascoe W., (1987) Fish oil prevents insulin resistance induced by high-fat feeding in rats. Science 237: 885-888.
114. Suzuki A., Lindor K., St Saver J., Lymp J., Mendes F., Muto A., et al. (2005) Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease. J Hepatol 43: 1060-1066.
115. 4). Exp Toxicol Pathol 46: 355-359.
116. Thoma C., Day C., Trenell M., (2012) Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review. J Hepatol 56: 255-266.
117. Toshimitsu K., Matsuura B., Ohkubo I., Niiya T., Furukawa S., Hiasa Y., et al. (2007) Dietary habits and nutrient intake in non-alcoholic steatohepatitis. Nutrition 23: 46-52.
118. Trovato F., Catalano D., Martines G., Pace P., Trovato G., (2015) Mediterranean diet and non-alcoholic fatty liver disease: the need of extended and comprehensive interventions. Clin Nutr 34: 86-88.
119. Ueno T., Sugawara H., Sujaku K., Hashimoto O., Tsuji R., Tamaki S., et al. (1997) Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J Hepatol 27: 103-107.
120. Van der Heijden G., Wang Z., Chu Z., Sauer P., Haymond M., Rodriguez L., et al. (2010) A 12-week aerobic exercise program reduces hepatic fat accumulation and insulin resistance in obese, hispanic adolescents. Obesity 18: 384-390.
121. Vilar-Gomez E., Martinez-Perez Y., Calzadilla-Bertot L., Torres-Gonzalez A., Gra-Oramas B., Gonzalez-Fabian L., et al. (2015) Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology 149: 367-378 e365; quiz e314-365.
122. Vitaglione P., Morisco F., Mazzone G., Amoruso D., Ribecco M., Romano A., et al. (2010) Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins. Hepatology 52: 1652-1661.
123. Wong V., Chan R., Wong G., Cheung B., Chu W., Yeung D., et al. (2013) Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial. J Hepatol 59: 536-542.
124. Wong V., Wong G., Yeung D., Lau T., Chan C., Chim A., et al. (2015) Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy. J Hepatol 62: 182-189.
125. Wouters K., van Gorp P., Bieghs V., Gijbels M., Duimel H., Lutjohann D., et al. (2008) Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. Hepatology 48: 486-474.
126. Xu C., Yu C., Xu L., Miao M., Li Y., (2010) high serum uric acid increases the risk for nonalcoholic fatty liver disease: a prospective observational study. PLoS One 5: e11578.
127. Yasutake K., Nakamuta M., Shima Y., Ohyama A., Masuda K., Haruta N., et al. (2009) Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol. Scand J Gastroenterol 44: 471-477.
128. Younossi Z., Stepanova M., Afendy M., Fang Y., Younossi Y., Mir H., et al. (2011) Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 9: 524-530
129. Younossi Z., Stepanova M., Negro F., Hallaji S., Younossi Y., Lam B., et al. (2012) Nonalcoholic fatty liver disease in lean individuals in the United States. Medicine 91: 319-327.
130. Zelber-Sagi S., Ben-Assuli O., Rabinowich L., Goldstein A., Magid A., Shalev V., et al. (2015a) The association between the serum levels of uric acid and alanine aminotransferase in a population-based cohort. Liver Int 35: 2408-2415.
131. Zelber-Sagi S., Buch A., Yeshua H., Vaisman N., Webb M., Harari G., et al. (2014a) Effect of resistance training on non-alcoholic fatty-liver disease a randomized-clinical trial. World J Gastroenterol 20: 4382-4392.
132. Zelber-Sagi S., Lotan R., Shlomai A., Webb M., Harrari G., Buch A., et al. (2012) Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up. J Hepatol 56: 1145-1151.
133. Zelber-Sagi S., Nitzan-Kaluski D., Goldsmith R., Webb M., Blendis L., Halpern Z., et al. (2007) Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study. J Hepatol 47: 711-717.
134. Zelber-Sagi S., Nitzan-Kaluski D., Goldsmith R., Webb M., Zvibel I., Goldiner I., et al. (2008) Role of leisure-time physical activity in nonalcoholic fatty liver disease: a population-based study. Hepatology 48: 1791-1798.
135. Zelber-Sagi S., Nitzan-Kaluski D., Halpern Z., Oren R., (2006) Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures. Liver Int 26: 856-863.
136. Zelber-Sagi S., Salomone F., Webb M., Lotan R., Yeshua H., Halpern Z., et al. (2015b) Coffee consumption and nonalcoholic fatty liver onset: a prospective study in the general population. Transl Res 165: 428-436.
137. Zelber-Sagi S., Salomone F., Yeshua H., Lotan R., Webb M., Halpern Z., et al. (2014b) Non-high-density lipoprotein cholesterol independently predicts new onset of non-alcoholic fatty liver disease. Liver Int 34: e128-e135.